You need to be logged in to view this video

Biotech Investing: The Covid-19 "Delta" Variant Means the Job Is Not Done

Released on Tuesday, August 10, 2021BIOTECH
Biotech Covid-19 vaccine development has demonstrated the power of biotech to change the world and make handsome returns for investors. With the Delta variant wrecking devastation worldwide, join this presentation to discover what's next. Can an oral vaccine be the difference maker to finally tame Covid-19?

John McCamant
Medical Technology Stock Letter, Editor

Trending Now

Filter By Category
Filter By Keywords